Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial-Reference-Cited by-同舟云学术

Intra-tumor injection of H101, a recombinant adenovirus, in combination with chemotherapy in patients with advanced cancers: A pilot phase II clinical trial

Published:2004 Issue:24 Volume:10 Page:3634
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:en
Short-container-title:WJG

Author:

Lu Wei

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference19 articles.

1. Gene Therapy for Cancer: What Have We Done and Where Are We Going?

2. Replication-selective virotherapy for cancer: Biological principles, risk management and future directions

3. Makower D, Rozenblit A, Kaufman H, Edelman M, Lane ME, Zwiebel J, Haynes H, Wadler S. Phase II clinical trial of intralesional administration of the oncolytic adenovirus ONYX-015 in patients with hepatobiliary tumors with correlative p53 studies. Clin Cancer Res 2003;9:693-702.

4. Assessment of growth inhibition and morphological changes in in vitro and in vivo hepatocellular carcinoma models post treatment with dl1520 adenovirus

5. Phase II Trial of Intravenous CI-1042 in Patients With Metastatic Colorectal Cancer

Cited by 97 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cancer therapy with the viral and bacterial pathogens: The past enemies can be considered the present allies;Life Sciences;2024-07

2. Oncolytic adenovirus in treating malignant ascites: A phase II trial and longitudinal single-cell study;Molecular Therapy;2024-06

3. Induced dual-target rebalance simultaneously enhances efficient therapeutical efficacy in tumors;Cell Death Discovery;2024-05-23

4. The combination treatment of oncolytic adenovirus H101 with nivolumab for refractory advanced hepatocellular carcinoma: an open-label, single-arm, pilot study;ESMO Open;2024-02

5. Oncolytic Virus Engineering and Utilizations: Cancer Immunotherapy Perspective;Viruses;2023-07-28